Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Approving QC Results – V 2.0

Posted on By

SOP for Approving QC Results – V 2.0

Procedure for Approving QC Results

Department Quality Control (QC)/Quality Assurance (QA)
SOP No. SOP/Ointment/088
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define a systematic approach for approving Quality Control (QC) test results in ointment manufacturing. This ensures that test results are accurate, meet Good Manufacturing Practices (GMP), and comply with product specifications before product release.

2. Scope

This SOP applies to all personnel in the Quality Control (QC) and Quality Assurance (QA) departments responsible for reviewing, verifying, and approving QC test results for raw materials, in-process samples, and finished products.

3. Responsibilities

  • QC Analyst: Conducts quality control tests and records test results.
  • QC Supervisor: Reviews test results and ensures they meet acceptance criteria.
  • QA Officer: Cross-checks QC data for completeness and accuracy.
  • QA Manager: Approves QC test results before batch release.
See also  Ointments: SOP for Overwrapping and Shrink-Wrapping - V 2.0

4. Accountability

The QA and QC Managers are accountable for ensuring that QC results are reviewed, approved, and documented as per GMP and regulatory requirements.

5. Procedure

5.1 QC Data Review Process

  • Ensure that all QC test results are recorded in the QC Test Report.
  • Verify that raw data, instrument logs, and calibration records are complete.
  • Check that QC tests were performed according
to validated methods.

5.2 Verification of QC Test Results

5.2.1 Raw Material Testing

  • Confirm that raw material test results meet predefined specifications.
  • Ensure that raw material Certificate of Analysis (CoA) is reviewed and approved.

5.2.2 In-Process Testing

  • Verify test results for pH, viscosity, and microbial contamination.
  • Ensure that in-process test results meet process control parameters.

5.2.3 Finished Product Testing

  • Check assay, microbial limits, and packaging integrity test results.
  • Confirm that all test results meet final product specifications.

5.3 Handling Out-of-Specification (OOS) Results

  • Identify test results that do not meet acceptance criteria.
  • Initiate an OOS investigation following OOS procedures.
  • Implement corrective and preventive actions (CAPA) if required.

5.4 Final Approval of QC Test Results

  • Ensure all QC test results are reviewed by the QC Supervisor.
  • QA Officer cross-verifies the QC data and signs off on test results.
  • QA Manager provides final approval for batch release.

5.5 Documentation

  • Record all approved QC test results in the QC Test Log.
  • Ensure traceability of test reports for future audits.
  • Store all test results securely for regulatory inspections.

6. Abbreviations

  • GMP – Good Manufacturing Practices
  • QA – Quality Assurance
  • QC – Quality Control
  • CoA – Certificate of Analysis
  • OOS – Out of Specification
  • CAPA – Corrective and Preventive Action

7. Documents

  • QC Test Report (Annexure-1)
  • QC Test Approval Log (Annexure-2)

8. References

  • WHO GMP Guidelines for Pharmaceutical Manufacturing
  • USP <1225> – Validation of Compendial Procedures
  • ICH Q6A – Specifications: Test Procedures and Acceptance Criteria

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: QC Test Report

Date Batch Number Test Parameter Result Acceptance Criteria Status Reviewed By
01/02/2025 OINT-101 pH 6.5 5.5 – 7.5 Pass QC Supervisor
01/02/2025 OINT-102 Microbial Limits Compliant Absent Pass QC Supervisor

Annexure-2: QC Test Approval Log

Date Batch Number Test Type Result Final Approval Status Approved By
01/02/2025 OINT-101 Final Release Testing Pass Approved QA Head
02/02/2025 OINT-102 Final Release Testing Pass Approved QA Head

12. Revision History:

Revision Date Revision No. Details of Revision Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP QA Head
01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: Tablets: SOP for Conducting Stability Testing in Controlled Environments – V 2.0
Next Post: SOP for Machine Maintenance and Troubleshooting

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version